Researchers have made significant progress in understanding the aging process and ways to potentially enhance lifespan.
This study, conducted at Queen Mary University of London, identified that an ancient enzyme known as AMPK plays a crucial role for cells in times of low energy.
Interestingly, the enzyme not only extended the lifespan of varied organisms, including fruit flies, nematodes, and fission yeast, but also indicated its importance in the context of aging.
The findings, published in Aging Cell, suggest that AMPK could be a promising target for future longevity research and healthy aging strategies in humans.
According to the researchers, AMPK essentially functions as a fuel sensor for cells. When energy levels dip, it helps by boosting energy production and recycling while simultaneously curtailing growth.
While scientists have long suspected a link between this enzyme and aging, investigating its precise role has proven tricky, especially when it comes to drug testing.
In this research, a compound named 991 was utilized to bind to AMPK, thereby activating it. This approach allowed the team to examine whether directly triggering AMPK could influence lifespan outcomes.
The results revealed that activating AMPK with 991 extended the lifespan of the tested organisms. It’s worth noting, however, that the lifespan-extending effect was not observed in worms and yeast that lacked functional AMPK, indicating that AMPK activation was essential for this outcome.
Interestingly, the findings also highlighted that more isn’t always better. In fact, higher doses of 991 were found to shorten lifespan in some cases, which underscores the need for precise AMPK activation levels.
Additionally, when 991 was administered to mice, researchers noted the activation of AMPK after three weeks. However, no significant lifespan extension was observed in these mice. Still, the changes linked to longevity were present, suggesting that longer-term studies are needed to ascertain whether direct AMPK activation could positively influence mammalian lifespan and healthspan.
Charalampos Rallis, a genetics researcher at Queen Mary University of London and a co-author of the study, emphasized the enzyme’s essential role in helping cells manage low energy. He mentioned, “When a cell runs low on energy, AMPK is what kicks in to help it cope.”
Despite these promising insights, Rallis cautions against premature enthusiasm for supplements based on this research. He pointed out that excessive levels of the drug were actually detrimental in their experiments, illustrating that this “switch” requires careful management rather than an across-the-board activation.
This collaborative effort involved scientists from various institutions, including the MRC Laboratory of Medical Sciences, Imperial College London, the University of Cologne, the Francis Crick Institute, and Universite Claude Bernard Lyon 1.
The findings set the stage for further exploration into whether directly targeting AMPK might one day contribute to strategies aimed not just at prolonging life but also at helping people stay healthier for longer.
